| __timestamp | Apellis Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 21263000 |
| Thursday, January 1, 2015 | 13730311 | 18890000 |
| Friday, January 1, 2016 | 22978599 | 15295000 |
| Sunday, January 1, 2017 | 40303878 | 12944000 |
| Monday, January 1, 2018 | 105285576 | 13599000 |
| Tuesday, January 1, 2019 | 220968770 | 30391000 |
| Wednesday, January 1, 2020 | 299921000 | 13020000 |
| Friday, January 1, 2021 | 420869000 | 16287000 |
| Saturday, January 1, 2022 | 387236000 | 19943000 |
| Sunday, January 1, 2023 | 354387000 | 21042000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, Apellis Pharmaceuticals, Inc. and Vericel Corporation have demonstrated contrasting R&D investment strategies. Apellis, with a staggering 4,900% increase in R&D expenses from 2014 to 2023, underscores its commitment to pioneering treatments. In contrast, Vericel's R&D spending has remained relatively stable, peaking in 2019 with a modest 43% increase from its 2014 baseline.
These trends highlight the diverse strategies within the biotech sector, where innovation and fiscal prudence coexist.
R&D Spending Showdown: Sanofi vs Vericel Corporation
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Vericel Corporation
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Vericel Corporation
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Vericel Corporation
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Vericel Corporation and Dynavax Technologies Corporation